ArticleJournal of the Pediatric Orthopaedic Society of North America2026
Determination of Modified Waldenström Staging in Legg-Calvé-Perthes Disease Using Deep Learning.
Article in Journal of the Pediatric Orthopaedic Society of North America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Age and disease stage are critical factors in guiding management in Legg-Calvé-Perthes disease (LCPD). The modified Waldenström system is the most common staging system for LCPD but has only moderate inter-rater reliability. Deep learning (DL) has gained popularity in orthopaedics due to its potential to improve consistency/efficiency in determination of image-based classifications. The current study aimed to develop a DL model for determination of modified Waldenström staging from standard hip radiographs. Methods: Paired anteroposterior (AP) and frog-lateral hip radiographs from patients with confirmed LCPD treated at 2 tertiary care children's hospitals were included for model training/validation, hold-out testing, and external validation. Images of patients with skeletal dysplasias or other conditions were excluded. A modified Waldenström stage was assigned by the senior authors for each radiograph. A machine learning classification pipeline leveraging DL-automated extraction of clinically relevant and quantifiable parameters on AP/lateral radiographs was developed. Model performance was assessed on 2 separate LCPD classification schemes: early (Ia-IIa) vs late (IIb-IV) and the full classification. Results: A total of 2,164 images were included from institution 1. The DL pipeline had excellent segmentation metrics (dice coefficient = 0.93) and was able to extract and calculate epiphyseal parameters on AP/lateral radiographs within 12 s. On the hold-out testing set (n = 229 radiograph pairs), the model had an area under the receiver operating characteristic curve (AUROC) of 0.82 in classifying LCPD as either early or late stage. The most predictive parameters driving model decision-making were AP epiphyseal sclerosis and epiphyseal area. On external validation at institution 2 (n = 533 radiograph pairs), the AUROC was 0.75 when categorizing early vs late stages. Conclusions: The DL pipeline provided high accuracy in discerning early vs late stages of LCPD based on imaging parameters and moderate accuracy on the full classification, performing better at more advanced stages. Training the model on larger samples with more representation at earlier stages may improve accuracy. This has the potential to expedite and standardize staging for both clinical encounters and research. Key Concepts: (1)Deep learning can accurately classify early vs late-stage LCPD from standard hip radiographs.(2)Automated segmentation provides objective and quantifiable assessment of femoral morphology parameters pertinent to LCPD.(3)Artificial intelligence models could be applied to both clinical practice and research methodology as an automated tool for Waldenström staging.(4)Larger, multicenter datasets with greater representation of early stage LCPD imaging are needed to improve model performance and generalizability. Level of Evidence: III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.